ARS Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 10.86 M | $87.21 M | 0.00% | 11.02% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 8.29 M | $66.56 M | 0.00% | 8.41% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 8.00 M | $64.24 M | 29.03% | 8.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 7.50 M | $60.26 M | 0.00% | 7.61% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 5.98 M | $48.04 M | 88.83% | 6.07% |
| BLACKROCK, INC. | 05/13/2026 | 5.01 M | $40.25 M | -1.44% | 5.09% |
| ABRDN PLC | 04/29/2026 | 4.11 M | $33.03 M | 15.68% | 4.17% |
| SR ONE CAPITAL MANAGEMENT, LP | 05/14/2026 | 4.01 M | $32.22 M | 0.00% | 4.07% |
| STATE STREET CORP | 05/15/2026 | 3.64 M | $29.27 M | 13.07% | 3.70% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 3.28 M | $26.33 M | 28.92% | 3.33% |
| TYRO CAPITAL MANAGEMENT LLC | 05/14/2026 | 2.97 M | $23.84 M | 48.81% | 3.01% |
| 05/15/2026 | 2.54 M | $20.42 M | 100.00% | 2.58% | |
| UBS GROUP AG | 05/05/2026 | 2.26 M | $18.15 M | 2.24% | 2.29% |
| JANNEY MONTGOMERY SCOTT LLC | 04/22/2026 | 2.02 M | $16.19 M | 56.58% | 2.05% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.77 M | $14.24 M | -9.28% | 1.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.53 M | $12.26 M | -1.68% | 1.55% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 1.36 M | $10.93 M | 268.41% | 1.38% |
| BAMCO INC /NY/ | 05/15/2026 | 1.27 M | $10.22 M | 0.38% | 1.29% |
| THIRD POINT LLC | 05/15/2026 | 1.00 M | $8.03 M | 79.78% | 1.01% |
| GENERAL AMERICAN INVESTORS CO INC | 05/01/2026 | 727.15 K | $5.84 M | 29.86% | 0.74% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 724.22 K | $5.82 M | -10.81% | 0.73% |
| NEXTECH INVEST, LTD. | 05/15/2026 | 610.70 K | $4.90 M | -7.57% | 0.62% |
| K2 PRINCIPAL FUND, L.P. | 05/14/2026 | 559.70 K | $4.49 M | 5,387.23% | 0.57% |
| LEVIN CAPITAL STRATEGIES, L.P. | 05/13/2026 | 552.56 K | $4.44 M | -26.08% | 0.56% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 533.39 K | $4.28 M | -3.18% | 0.54% |
| NORTHERN TRUST CORP | 05/14/2026 | 529.28 K | $4.25 M | 1.59% | 0.54% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 525.22 K | $4.22 M | -7.21% | 0.53% |
| 05/08/2026 | 510.55 K | $4.10 M | 100.00% | 0.52% | |
| EMPIRE LIFE INVESTMENTS INC. | 05/11/2026 | 499.15 K | $4.05 M | 41.56% | 0.51% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 464.68 K | $3.73 M | 52.63% | 0.47% |
| FIL LTD | 05/15/2026 | 455.58 K | $3.66 M | -43.76% | 0.46% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 446.31 K | $3.58 M | 100.00% | 0.45% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 428.60 K | $3.44 M | -5.96% | 0.43% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 422.04 K | $3.39 M | 100.00% | 0.43% |
| JPMORGAN CHASE & CO | 05/13/2026 | 382.80 K | $2.99 M | -8.22% | 0.39% |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | 05/07/2026 | 359.07 K | $2.88 M | 15.27% | 0.36% |
| FMR LLC | 05/15/2026 | 342.04 K | $2.75 M | -14.27% | 0.35% |
| MORGAN STANLEY | 05/15/2026 | 316.67 K | $2.54 M | -42.67% | 0.32% |
| CENTERBOOK PARTNERS LP | 05/05/2026 | 291.18 K | $2.34 M | -48.77% | 0.30% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 285.73 K | $2.29 M | -40.73% | 0.29% |
| XTX TOPCO LTD | 05/15/2026 | 276.11 K | $2.22 M | 642.21% | 0.28% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 250.60 K | $2.01 M | 24.38% | 0.25% |
| TEJARA CAPITAL LTD | 05/12/2026 | 210.40 K | $1.69 M | 100.00% | 0.21% |
| FAS WEALTH PARTNERS, INC. | 06/10/2026 | 205.41 K | $1.65 M | 1.48% | 0.21% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 172.34 K | $1.38 M | -2.15% | 0.17% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 05/12/2026 | 168.79 K | $1.36 M | 100.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 164.06 K | $1.32 M | 0.65% | 0.17% |
| QUINN OPPORTUNITY PARTNERS LLC | 05/15/2026 | 155.00 K | $1.24 M | 0.00% | 0.16% |
| NUVEEN, LLC | 04/30/2026 | 150.70 K | $1.21 M | 0.73% | 0.15% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 146.45 K | $1.18 M | -32.29% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 234 institutional investors and hedge funds held shares of ARS Pharmaceuticals Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
ORBIMED ADVISORS LLC: 8.29 M
Rubric Capital Management LP: 8 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 7.5 M
MILLENNIUM MANAGEMENT LLC: 5.98 M
BlackRock, Inc.: 5.01 M
94.89% of ARS Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 99.88 M shares in the last 24 months. This purchase volume represents approximately $903.92 M in transactions.